Condition (MeSH)
Pulmonary Heart Disease
ClinicalTrials.gov lists 42 trials for Pulmonary Heart Disease or a narrower condition beneath it. Competence Network for Congenital Heart Defects has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
42 of the 42 trials are tagged with Pulmonary Heart Disease itself; the rest are tagged with a narrower condition beneath it.
When did Pulmonary Heart Disease trials start? (17)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 3 |
| 2024 | 3 |
| 2023 | 1 |
| 2022 | 4 |
| 2021 | 5 |
| 2020 | 2 |
| 2018 | 2 |
| 2017 | 2 |
| 2016 | 3 |
| 2014 | 3 |
Showing 10 of 17 earlier years.
No forecast is made for this condition: it averages 2.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 42 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Pulmonary Heart Disease trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 4 |
| Not applicable | 18 |
| Observational | 16 |
How many Pulmonary Heart Disease trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 2 |
| Completed | 26 |
| Terminated | 2 |
| Withdrawn | 3 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Pulmonary Heart Disease trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Competence Network for Congenital Heart Defects | 2 |
| Eli Lilly and Company | 1 |
| Gabi SmartCare | 1 |
| Hillel Yaffe Medical Center | 1 |
Which drugs are being tested for Pulmonary Heart Disease? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Nicotine Patch | 1 |
Interventions as named in the registry (6)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Indacaterol 37.5 | 1 |
| Definity Contrast | 1 |
| Bosentan administration | 1 |
| Chlorhexidine Gluconate Mouthwash | 1 |
| Nitrates | 1 |
Showing 5 of 6 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Pulmonary Heart Disease trials report? (1)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| rehospitalization | 310 | 1 |
Which publications cover Pulmonary Heart Disease? (37)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Lung Disease-Related Pulmonary Hypertension. | Cardiology clinics | 2022 | Yes |
| Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study. | American journal of respiratory and critical care medicine | 2019 | Yes |
| A cross-sectional study of acute cor pulmonale in acute respiratory distress syndrome patients in China. | Chinese medical journal | 2019 | Yes |
| Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact. | Intensive care medicine | 2016 | Yes |
| Acute respiratory distress syndrome: the heart side of the moon. | Current opinion in critical care | 2016 | Yes |
Showing 5 of 37 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.